Saturday, February, 23, 2019 01:55:21

Category: Pharmaceuticals

CherryCircle Software raises $2.3m to advance its software innovations

 The investment round saw the participation of Hudson Park Capital, PLH Business Ventures, ATX Seed Ventures, and several other industry veterans.  CherryCircles’ software lets the pharma companies to capture development knowledge over time and handle risk across numerous dimensions with data. The US-based CherryCircle Software, …

Dr Reddy’s declares launch of Propofol Injectable Emulsion in the U.S.

Renowned pharmaceuticals company Pharma major Dr Reddy’s Laboratories Ltd., has reportedly brought the Propofol Injectable Emulsion to the U.S. shores. Propofol, a therapeutic generic equivalent version of Diprivan (propofol) Injectable Emulsion, has been given the green signal by the U.S. Food and Drug Administration and …

Wockhardt receives USFDA nod for cancer drug, Imatinib Mesylate

Imatinib Mesylate is claimed to stop the growth of cancer cells and is prescribed for treating Leukemia and certain Gastro-Intestinal tumors. Renowned pharmaceutical and biotechnology company, Wockhardt, recently received the USFDA approval for an ANDA for 100 mg and 400 mg tablets of Imatinib Mesylate. …

ASLAN Pharmaceuticals reveals results from Phase 2 study of Varlitinib

The study shows improvement in PFS in patients treated with metastatic gastric cancer therapy varlitinib. Renowned clinical-stage biopharmaceutical firm, ASLAN Pharmaceuticals has recently announced an update on the global placebo-controlled phase 2 clinical study of varlitinib, as first-line therapy in metastatic gastric cancer patients, while …